Real-World Cost Effectiveness of a Policy of KRAS Testing to Inform Cetuximab or Panitumumab for Third-Line Therapy of Metastatic Colorectal Cancer in British Columbia, Canada.

Pataky, Reka E; Bryan, Stirling; Sadatsafavi, Mohsen; Peacock, Stuart; Regier, Dean A

Pataky, Reka E; Bryan, Stirling; Sadatsafavi, Mohsen; Peacock, Stuart; Regier, Dean A.

Afiliação

Pataky RE; Canadian Centre for Applied Research in Cancer Control, Cancer Control Research, BC Cancer, Vancouver, BC, Canada. rpataky@bccrc.ca.
Bryan S; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. rpataky@bccrc.ca.
Sadatsafavi M; BC Cancer Research Centre, 675 W. 10th Ave, Vancouver, BC, V5Z 1L3, Canada. rpataky@bccrc.ca.
Peacock S; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
Regier DA; Centre for Clinical Epidemiology and Evaluation, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada.

Pharmacoecon Open ; 7(6): 997-1006, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37819586

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 Problema de saúde: 1_financiamento_saude Tipo de estudo: Evaluation_studies / Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: Pharmacoecon Open Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google